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INTRODUCTION 
2 
Secretory immunity is believed to play a role in natural 
resistance to dental caries. Although dental caries has dramatically 
decreased in children in the United States, there remains a 
population of caries-susceptible children even in fluoridated 
communities. Previous studies have shown a positive correlation 
between salivary immunoglobulin A (slgA) antibody levels to 
Streptococcus mutans and caries resistance in adults. The goal of 
this research study was to investigate the role of the immune 
response in natural protection against caries in children by 
examining and comparing the amounts of lgA antibodies to S. mutans 
among caries-resistant and caries-susceptible children. This was 
performed by collection of whole and parotid saliva, analysis of 
antibody activity by enzyme-linked immunosorbent assay and 
bacterial numbers by spiral plated cultures, and by comparison 
between the caries-resistant and caries-susceptible subjects. 
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REVIEW OF LITERATURE 
4 
Despite significant advances in dental caries prevention, 
dental decay continues to be a problem throughout much of the 
world. The preventive measures against dental caries in developed 
countries have proven to be quite effective, reflected in a continued 
decrease in caries prevalence over the past 20 years. The National 
Institutes of Health reported as recently as 1 980 that the mean 
number of decayed, missing, and filled permanent tooth surfaces in 
United States adolescent population has increased from 5.41 for 13-
year-olds to 11.04 for 1 7 -year-olds. However, it is evident that 
preventive pit and fissure sealants and the use of fluorides continue 
to be relied upon for caries control. According to Nowak and Crall1 
other factors such as dietary habits and motivation continue to play 
major roles in caries rate. Smith2 and Diesendorf3 report that in 
most undeveloped countries dental decay remains the most common 
form of human disease. The main cause for continued dental disease 
is simply the economic barriers that prevent the provision of dental 
health care and education to the population of the these undeveloped 
countries. These economic barriers include the finances to start the 
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preventive care programs such as water fluoridation, preventive 
dentistry, and nutritional education. Another report by Smith4 
indicates that these economic barriers coupled with increased sugar 
intake especially in the younger population have actually led to 
increasing caries rates in developing countries. Data from the 
World Health Organization estimate that the average 1 4-year-old in 
developing countries has four decayed teeth. s Therefore, it is 
imperative that more cost-effective means of preventing dental 
caries must be developed. This can be accomplished by continuing 
research in caries prevention in the area of caries immunization. 
The role of Streptococcus mutans in dental caries 
It has long been known that microorganisms were involved in 
disease, but it was not until the 1 880s that Miller's6 experiments 
placed dental caries into the category of a bacterial disease. Miller 
demonstrated that, in the presence of carbohydrate, salivary 
bacteria could demineralize tooth enamel. He, therefore, postulated 
that the etiologic agents of dental caries were bacteria and that 
their acidic and proteolytic products caused destruction of the 
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mineral and organic components of the teeth. Miller isolated several 
types of bacteria that were capable of producing large amounts of 
acid and concluded that no single species was responsible for dental 
caries and that any bacteria capable of producing acid could cause 
decay. 
The involvement of Streptococcus mutans in the dental caries 
process was first proposed almost 70 years ago. In 1924 Clarke? 
isolated S. mutans from human carious lesions and recognized its 
potential role in the etiology of dental caries. Clarke named the 
microorganism S. mutans because the isolated organisms had a 
tendency to be somewhat pleomorphic, that is, possessing either 
cocci chains or short rods. He proposed that the acidogenic and 
aciduric properties of S. mutans may be responsible for dental 
decay. 
The early report by Clarke was mostly ignored by the 
scientific community for 30 years. Later, with the development of 
gnotobiotic animal technology, experiments confirming the 
bacterial etiology of dental caries were conducted. In 1 955 Orland 
and associates8 demonstrated that germ-free rats fed high sucrose 
diets were caries-free. When subsequently monoinfected with 
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streptococcal species, these animals developed dental caries. 
Orland's experiments proved the involvement of bacteria by 
demonstrating that in the absence of bacteria, dental caries did not 
develop. In 1 960 Keyes9, 1 o performed experiments that established 
that dental caries was an infectious disease. He treated hamster 
dams with antibiotics during pregnancy and lactation and produced 
caries-inactive offspring. These caries- inactive pups failed to 
develop extensive lesions unless they were caged with animals 
exhibiting rampant decay or were supplied with fecal material from 
carious animals and consequently became orally infected due to 
coprophagous habits. Later, Fitzgerald and Keyes11 were able to 
isolate certain streptococci from carious lesions in hamsters. They 
innoculated the mouths of the caries-free hamsters with these 
bacteria and the hamsters exhibited rampant decay. Their work 
further suggested that certain strains of oral streptococci may be 
responsible for dental decay, the principal being S. mutans. 
Although these extensive studies suggested that S. mutans had 
an etiologic role in dental caries, it was not until the 1 970s that 
Loesche and others provided definitive evidence that demonstrated 
that S.mutans was the etologic agent of human dental caries. 
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Loesche and associates12-14 used associative, longitudinal, 
virulence, and response-to-treatment studies to provide this 
evidence, and the role of S. mutans in human dental decay has since 
stimulated an enormous research effort. 
Studies by Bratthalf15 and by Perch et af.16 have divided the S. 
mutans isolates into eight serotypes (a-h) based on differences in 
the cell wall carbohydrates. These serotypes exhibit cross-
reactivity, especially between serotypes a, d, g, and h and serotypes 
c, e, and f. DNA hybridization studies by Coykendalf17 divide these 
isolates into four genetic groups based on the percentage of guanine 
and cytosine (G + C in the DNA). Mutans streptococci currently have 
the following species designations: human isolates that resemble 
Clarke's originally identified strain are classified as S. mutans and 
represent serotypes c, e, and f (36 to 38 percent G + C), with S. 
mutans serotype c being the most prevalent mutans streptococci 
isolated from human dental plaque. Loesche 11 reports that 
Streptococcus sobrinus consists of serotypes d, g, and h human 
isolates ( 44 to 46 percent G + C). Streptococcus cricetus are the 
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serotype a isolates ( 42 to 44 percent G + C) and Streptococcus 
rattus are serotype b isolates ( 41 to 43 percent G + C). 
The probable role of S. mutans in dental decay prompted 
investigators to conduct further examinations of immunity to S. 
mutans in caries susceptible and caries resistant individuals to 
determine the extent to which an immune response to this organism 
plays a role in natural resistance to caries. 
Immune response studies 
Michalek and Childers18 reviewed that secretory 
Immunoglobulin A (slgA) has been identified as the principal 
immunoglobulin isotype present in external secretions and as the 
main humoral element of the secretory immune system. SlgA is 
known to neutralize viruses, bacterial exotoxins, and enzymes that 
contribute to disease processes and to inhibit the attachment and 
adherence of oral bacteria to epithelial and tooth surfaces. Thus, 
the induction of a slgA antibody response to S. mutans antigens it 
would seem helpful in the development of a caries immunization. 
Different routes of immunization are believed to exist from 
which an antibody response could be induced by S. mutans antigens. 
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One route postulates that the humoral immune response of serum 
lgG to S. mutans antigen may play an important role in natural 
immunity to dental caries. The basis of this postulation is that 
there is an exposure of blood to the oral cavity at the time of tooth 
eruption and then following eruption via crevicular fluid. In 1 970 
Attstron and Egelberg19 suggested that crevicular fluid may be the 
vehicle of lgG antibody-mediated reductions in experimental dental 
caries in animals immunized with S. mutans antigens, and then in 
1 986 Krasse et ai.ZO suggested that immune components from serum 
can enter the oral cavity during the eruption process. In order to 
provide mechanisms for this, Riott and LehnerZ1 theorized that 
antigens on the surface of microorganisms are phagocytized by 
macrophages in sites other than the oral cavity. This allows 
antigenic materials to be processed and become associated with the 
surface of the macrophages and then to be presented to B and T 
lymphocytes. The B-lymphocytes are activated and, with assistance 
from helper T -lymphocytes, remain in lymphoid tissue in the oral 
cavity and differentiate into plasma cells which in turn produce 
antibodies. This results in the release of specific lgG antibodies in 
1 1 
the oral cavity that are capable of binding to antigen. The plasma 
cells only survive two to three days but memory 8-lymphocytes, 
which are derived from the 8-lymphocyte population, may be present 
for several years. 
However, one report by 8ienenstock et al.22 and another by 
Mestecky et al.23 have provided considerable evidence that indicates 
that exposure of lymphocytes to the oral cavity is not the major 
pathway leading to a secretory immune response. Secretions of 
glands such as mammary, salivary, and lacrimal contain slgA 
antibodies to antigens that have never been present in the gland. 
Since slgA in secretions is locally produced by plasma cells in the 
gland, it follows that precursors of lgA 8 cells home to these glands 
after prior stimulation in lgA inductive sites. This supports the 
postulation that a common mucosal immune system exists. 
According to the postulation antigens are swallowed or inhaled, in 
this case the S. mutans bacteria, then taken up by specialized 
phagocytic antigen-presenting epithelial cells (microfolding or M 
cells) which in turn stimulate lgA precursor 8 and regulatory T cell 
activity in gut-associated lymphoreticular tissue (GALT) (i.e. 
Peyer's Patches), and bronchus-associated lymphoreticular tissue 
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(BAL T), respectively. These cells then migrate through the 
circulation and lymphatics to distant mucosal sites including the 
lamina propriae of the gastrointestinal, respiratory, and 
genitourinary tracts and the salivary, lacrimal and mammary glands 
and differentiate into plasma cells. The plasma cells are found in 
subepithelial areas where they produce and actively secrete 
antibodies. Secretory component (SC), which serves as the lgA 
receptor on secretory epithelial cells, selectively binds to the J-
chain containing lgA. SC is produced by the secretory epithelial 
cells that line the intestinal tract and acinar and ductal cells of the 
secretory glands. The SC then acts as a transporting protein to 
translocate the lgA:J chain:SC complex from the distal surface of 
the epithelial cell into an external secretion (Figure 1 ). SC also 
makes slgA more resistant to the nonspecific proteolytic enzymes 
of the Gl tract. 
External secretions containing slgA can neutralize enzymes, 
toxins and viruses as well as prevent the absorption of antigens 
from the Gl tract. SlgA also has been found to affect bacterial 
adherence to the epithelial lining of the mucosal surfaces of the 
gastrointestinal, respiratory, and genitourinary tracts. 
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The initial evidence for the existence of a common mucosal 
immune system came from studies in animals. Rudzik24 showed that 
lymphoid cells from Peyer's patches of rabbits, when injected into 
irradiated allogeneic recipients, repopulate the lamina propria of 
the intestine with lgA-producing plasma cells of the donor type. It 
was also shown that BAL T lymphocytes could do the same. Michalek 
et al.18 recently demonstrated B cells in the peripheral blood 
circulation with the potential to produce lgA antibodies to oral 
vaccine antigens, which has provided additional evidence for the 
existence of a common mucosal immune system in humans. Much 
remains to be done to determine the mechanisms involved in the 
induction and regulation of mucosal responses and to establish the 
optimal dose and form of oral antigens to be used in humans for 
induction of protective slgA repsonses to microbial pathogens, 
including oral pathogens. 
Immunization studies 
With the establishment of a bacterial etiology for decay, 
Wagnerzs explored the possibility that the immune response plays a 
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role in natural protection from dental caries. Building upon the work 
of earlier investigators, Wagner reported in 1967 that gnotobiotic 
rats monoinfected with a strain of Streptococcus faecalis, either by 
oral inoculation or parental injection of the homologous bacterium 
in adjuvant, were immunized against dental caries. This 
immunization resulted in the virtual elimination of cariogenic 
activity seen in the non-immunized gnotobiotic control rats. The 
immunized and protected rats had higher anti-S. faecalis serum and 
higher salivary agglutinin titers and fewer S. faecalis in their saliva 
than did their non-immunized counterparts. His findings suggested 
that antibody is produced against the cariogenic bacterium and is 
secreted into the serum and the saliva. In the immunized 
gnotobiotic rat challenged with S. faecalis, the incidence of caries 
was reduced. This investigation was conceived as a first step to 
test the possible protection conferred by immunization and was 
designed to examine the possibility that there were differences in 
serum antibody levels against known cariogenic streptococci in a 
caries-free and a caries-rampant human population. 
In the mid 1 970s McGhee and associates26 and Taubman and 
Smith27 provided further evidence that immunization procedures in 
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rats were possible. S. sobrinus whole cells were injected into the 
salivary glands of rats resulting in salivary antibodies that 
correlated with protection against dental caries. These studies 
provided evidence that site-restricted (salivary) lgA responses can 
be induced by local immunization and were the first to show a direct 
correlation between the appearance of salivary lgA anti-S. sobrinus 
antibodies and protection against S. sobrinus-induced caries 
formation. Taubman and Smith's28-32 work further suggested that S. 
sobrinus glucosyltransferase (GTF) was an effective antigen in 
rodents for inducing caries immunity. The salivary lgA anti-S. 
sobrinus GTF antibodies correlated with protection against carious 
lesions from S. sobrinus as well as S. mutans. Taubman and Smith33 
also showed that the induced salivary lgA anti-GTF antibodies were 
shown to block s. sobrinus plaque formation in vitro. Van deRijn34 
expressed a concern that a potential existed for cross-reactivity of 
S. mutans antibodies to human muscle, kidney and heart tissues. 
However, building on the suggestions from Taubman and Smith's 
studies, Michalek et ai.3S-37 demonstrated that the oral 
administration of s. sobrinus whole cell antigen to gnotobiotic rats 
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induced a secretory lgA immune response and that the appearance of 
specific salivary lgA antibodies correlated with caries immunity 
without a serum response which would minimize the potential 
pathology of human cross-reactive antibodies. 
Further studies with rats performed by Michalek et al.37 
examined different types of immunogens from S. mutans. It was 
found that particulate antigens were more effective oral 
immunogens in inducing salivary immune responses than soluble 
forms. Several other studies examined the use of particulate 
antigens that were placed directly into the stomachs of rats. These 
studies, performed by Cox,38 Kiyono,39 and Ebersole,40 agreed that 
when particulate antigens were placed directly into the rats' 
stomachs, there was a higher secretory immune response as 
compared to when soluble forms were given by the oral route due to 
the more efficient uptake and processing of particulate antigens by 
GALT. 
Michalek et al. 18 next showed that the use of liposomes to 
present S. mutans antigens to GALT induced higher levels of 
response in rats than just the antigens alone. Morisaki et al.41 then 
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investigated the possibility of using soluble adjuvants such as 
muramyl dipeptide and peptidoglycan to enhance secretory immune 
responses when given orally with streptococcal antigens, and they 
found an enhanced salivary lgA immune response in rats. Taubman et 
al. 32 also showed that intragastric immunization with soluble 
adjuvants resulted in an enhanced response. These and other 
experiments provided evidence that soluble adjuvants are effective 
orally and that they augment lgA immune responses to S. mutans 
antigens. 
Caries risk 
Loesche42 reported that the presence of S. mutans in a mouth 
is not a useful diagnostic criterion because almost all individuals 
harbor S. mutans on their teeth and in their saliva. It is the level of 
colonization of the teeth that determines the risk of decay. He 
suggested that the most appropriate way to determine numbers of S. 
mutans was by quantitative culturing of plaque from indicator teeth, 
such as occlusal fissures of first molars, or by culturing the saliva. 
He reported that since saliva is easier to handle and with the 
availability of a selective medium for S. mutans information on the 
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salivary levels of S. mutans can be routinely obtained by any 
hospital microbiology laboratory. Bratthall43 has also reported the 
use of a semiquantitative method within the dental office using 
tongue blades and selective media to identify high-caries risk 
groups. 
Klock and Krasse44 reported that children who have salivary S. 
mutans numbers above 1 .OE+06 cells/ml should be considered as 
being a high-caries risk. Loesche6 expanded on this information by 
adding that single occlusal fissures can be colonized from the saliva 
by as few as 3.0E+03 S. mutans!ml of saliva, whereas about 4.5E+04 
S. mutans/ml are needed to reliably colonize a smooth surface. This 
would suggest that if the laboratory report for S. mutans was in the 
vicinity of 1 .0E+03 ml to 1 .OE+04/ml, the patient would not be at 
high risk for caries, but if the value were over 1 .0E+06/ml, he would 
be at high risk. Loesche concluded that laboratory cultures should be 
able to recognize those patients at high risk who need concurrent 
anti-S. mutans therapy in conjunction with their restorative 
treatment. 
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Loesche 1 2 reported in another study that it is important to 
determine the caries-active versus the caries-inactive and caries-
free patients. He defines caries active as at least one decayed tooth 
surface (D> 1 ), caries inactive as no decayed tooth surfaces (D=O), 
and caries free as no decayed, filled or missing (because of decay) 
tooth surfaces (D=O). He felt that patients should be divided by the 
magnitude of their current or past caries experience. For instance, 
when a DMFS score of five was used as the cut off point between low 
or high initial caries scores, a negative correlation between 
lactobacillus numbers and initiation of decay was suggested in the 
low-caries active subjects, whereas a highly positive correlation 
between S. mutans numbers and initiation was found in the high 
caries-active children. 
Natural immunity 
The major emphasis of most caries immunization 
investigations involves the attempt to enhance the natural immunity 
to human dental caries. Since the cause of dental caries is a result 
of the chronic and cyclic process of demineralization, it is 
reasonable that if antibodies can block attachment or interfere with 
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bacterial cell function then their enhancement may help prevent 
dental caries. lgA constitutes the majority of immunoglobulins 
present in the oral cavity and in the entire body and consists of two 
subclasses, lgA 1 and lgA2. Delacroix et ai.4S identified that lgA 1 
makes up approximately 60 percent and lgA2 makes up 
approximately 40 percent of the total lgA. Smith and Taubman46 
have reported that adult parotid saliva contains 30 to 1 60 J.Jg/ml of 
lgA and is almost entirely secretory lgA. lgM and lgG are also 
present but in significantly lower concentrations. Adult whole 
saliva is usually in the same proportions as infant whole saliva 
except that minor salivary glands contribute more lgM and lgG in 
infants. It must also be noted that Smith, King, and Taubman47 
observed that essentially all lgA in whole saliva of predentate 
infants is of secretory origin, that adult salivary lgM/IgA 
proportions are achieved early in life, but that, at least in some 
infants, the salivary lgA subclass levels are still changing during 
this time. 
However, it is well known that salivary lgA is not present at 
birth but develops during the first months of life to become the 
21 
dominant immunoglobulin. As reviewed by Michalek and Childers, 18 
initial protection is believed to be provided in three ways: 
nonimmune factors such as epithelial barrier and peroxidase 
enzymes; maternal, placentally transferred lgG antibodies; and lgA 
antibodies in breast milk. It is believed that the immune response 
to cariogenic organisms may develop during bacterial colonization 
and eruption of deciduous teeth in the human infant. Kohler and 
Bratthall48 have reported that the oral cavity of the infant becomes 
rapidly colonized, primarily by organisms derived from the mother. 
Carlsson49 and colleagues have followed a group of children from 
birth to 5 years of age in order to determine the progression of 
colonization of oral microorganisms. First to appear in the oral 
cavity soon after birth is Streptococcus salivarius. Streptococcus 
mitis dominates by 1 to 5 months of age followed by Streptococcus 
sanguis when the first teeth erupt at about 6 months of age. Mutans 
streptococci are usually not found in appreciable levels until the 
second or third years of life. This colonization progression provides 
guidelines by which the selection of streptococcal antigens to use in 
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probing secretory immune responses in the saliva of the infant can 
be made. 
Camling and Kohler, so as well as others, have reported that 
between the age of 1 and 5 years, salivary lgA antibody has been 
detected to several mutans streptococcal species, including S. 
mutans. Smith51 reports in a longitudinal study that the lgA 
antibody level to S. mutans continues to increase from 5 months to 3 
years of age and Gahnbergsz confirms similar findings in the age 
group from 2 to 48 months of age. 
The immune response of infants is important in determining 
the pattern of colonization of microorganisms in the mouth. Ivanyi 
and Lehners3 investigated the comparative maternal-fetal immune 
responses to S. mutans. Their investigations revealed maternal lgG 
but not lgM isotype of antibodies to S. mutans in neonatal blood and 
that sensitization of neonatal lymphocytes to S. mutans occur in 
utero. As mentioned earlier, it is believed that systemic humoral 
and cellular immune components enter the mouth predominantly 
through the gingival crevice (Attstrom and Egelberg19). This led 
researchers to believe that there may be a critical timing between 
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the eruption of deciduous teeth and the physiological clearance of 
maternal antibodies about 5 months after birth, as well as the 
duration of sensitization of lymphocytes, which may influence the 
colonization of plaque bacteria. 
Some researchers have even suggested that an effective way 
to prevent dental caries may be to delay the initial colonization of 
S. mutans in the human mouth. Camling, Gahnberg and KrasseS4 
hypothesized that several factors could delay colonization such as 
exposure to low numbers of S. mutans, a low sucrose diet, or 
salivary factors such as secretory lgA. Camling and Kohlerso 
further suggested that lgA antibody activity to S. mutans specific 
serotype c antigen and S. mutans serotype c whole cells was 
significantly higher in children with more than two decayed or 
filled surfaces as compared to children who were caries free. 
Aaltonen and associatesss presented data suggesting that the 
amount of anti-S. mutans antibodies occurring in maternal serum 
and saliva is influenced by the maternal antigenic load. They found 
that if mothers had dental treatment during pregnancy their S. 
mutans numbers decreased and that there was a correlation with 
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their decreased serum levels of antibodies to S. mutans, which 
resulted in increased caries in their breast-fed infants. They 
proposed two explanations for these findings: differences in 
transplacental passage of lgG antibodies and/ or differences in 
postpartum transfer of S. mutans to the infant. 
Breast milk plays an important role in the passive transfer of 
antibodies to the newborn. Mellander, Carlsson and Hansons6 
reported little slgA is found in the infants saliva in the first few 
months after birth. They found that the main source of lgA for the 
baby comes from the mother's breast milk and it is not until the age 
of about 1 2 months that adult levels of slgA are reached. It has 
been estimated by Brandtzaegs7 that as much as 1 g/day of 
immunoglobulin is received by infants from breast milk. It is 
believed that breast milk lgA antibodies interfere with mucosal 
binding of microorganisms and prevent exposure to food proteins. 
Tank and Storvick58 found that breast-fed infants were less 
susceptible to caries; however, it must be noted that there is a 
conflicting report by Camling et ai.S9 as to how important a role the 
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protection provided by breast milk antibodies plays in caries 
prevention. 
Recent human immunization studies 
Several human studies have been attempted including the 
Hughes et al. 60 report of the use of a purified surface protein of S. 
mutans to stimulate a systemic immune response to S. mutans 
antigen, which indicated no increase in the level of cross-reactive 
antibodies to human tissues. Then, the first protection from S. 
mutans colonization by oral immunization in humans was provided 
by Gregory and Filler61 who demonstrated that the ingestion of a 
vaccine containing killed S. mutans induced increased levels of 
specific slgA antibodies to S. mutans cells and two cell surface 
proteins, GTF and surface antigen 1/11, in tears, saliva, colostrum 
and milk. These investigations provided additional evidence for the 
existence of a common mucosal immune system in humans and of 
memory in this system. However, Gahnberg and Krasse62 as well as 
Cole et al.63 were unable to demonstrate an elevation in salivary 
lgA antibody levels in humans following oral administration of 
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mutans streptococcal antigen but noted that there was a decrease in 
the level of implanted mutans streptococci following immunization 
with mutans streptococcal antigen. Mestecky et al.64 have recently 
conducted experiments in which human volunteers were given S. 
mutans whole cells in enteric-coated capsules by the oral route. 
Using the enzyme-linked immunospot assay (ELISPOT), it was shown 
that spontaneous antibody-forming cells were present in the 
circulation within seven days. Most of the cells produced antibodies 
of the lgA isotype. Peak levels of slgA anti-S. mutans antibodies in 
external secretions from these subjects were seen by day 21 . No 
increase in the levels of anti-S. mutans antibodies was seen in the 
sera of these volunteers. This provided additional evidence for the 
common mucosal immune system. More recently, studies by 
Taubman and Smith65 provided further evidence for the induction of 
a salivary lgA immune response in humans following ingestion of a 
vaccine containing purified GTF from S. mutans. M. Russell, 
Challacombe, and Lehner66 and R. Russell67 reported that the surface 
of S. mutans is composed of many different macromolecules, 
including GTF, fructosyltransferase, protein surface antigens 1/11 
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and Ill, proteins A, B, C and P1, SpaA, IF and glucan-binding protein, 
serotype carbohydrates, lipoteichoic acid, and glucans. After 
immunizing monkeys with antigens 1/11 and/or A and C from 
serotype c mutans streptococci, Russell68 observed a protective 
effect. The protein antigens B, IF, and PI of mutans streptococci 
appear to share cross-reactive antigens with heart tissue. Of 
important note was that GTF did not share any cross-reacting 
epitopes with human tissue and therefore seems to be a potentially 
significant antigen. The results of this study and of previous work 
by this group strongly support the potential use of GTF for use in an 
oral caries vaccine for humans. 
Furthermore, data from Taubman and Smith's studies suggest 
that salivary lgA may play a very important role in the 
neutralization of S. mutans enzymes. Gregory et al. 69,70 reported 
that S. mutans enzymes most affected by saliva include glucose-
phosphotransferase, which transports glucose across the cell 
membrane. The inhibition of the enzyme would result in decreased 
growth, acid production, and all other metabolic activites of the 
cell. Another previously identified enzyme neutralized was GTF, an 
enzyme that synthesizes water insoluble and soluble glucans. If 
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these water insoluble glucans are not formed, then S. mutans 
exhibits a decrease in adhesive ability, therefore decreasing 
colonization on tooth structure. 
Curtiss et al.71 have taken a different approach to developing 
an oral vaccine by using an avirulent Salmonella mutant as a carrier 
of cloned genes encoding virulence antigens of mutans streptococci. 
If avirulent derivatives of Salmonella are endowed with ability to 
produce S. mutans cell-surface proteins, the avirulent Salmonella 
would home to the GALT cells to elicit production of a secretory 
immune response against Streptococcal proteins and engender 
protective immunity against S. mutans. Curtiss et al. 71 have shown 
that peroral immunizations lead to stimulation of slgA against spaA 
and GTFA S. mutans cell surface proteins and are planning to 
investigate enhancement of immune responses and the occurence of 
oral tolerance. 
Lehner et al. 72 demonstrated that systemic immunization was 
possible by using purified sa 1/11 to prevent the colonization of S. 
mutans in the oral cavity and subsequent dental caries development. 
Lehner et al. 73 provided evidence that serum lgG antibodies gain 
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access to the oral cavity by transudation through the gingival 
crevice to effect protection. Furthermore, studies by Challacombe 
and Lehner74 suggested a correlation between S. mutans antigen and 
salivary lgA levels in primates, which were given S. mutans 
antigens in their drinking water. It must be noted that systemic 
immunization approaches are unlikely to be used in humans until the 
questions about the role of crevicular fluid in dental caries 
immunity and the potential for cross-reactivity of S. mutans 
antibody with human heart tissue are answered. 
Present study considerations 
Gregory et al. 70 has also demonstrated that there were 
significantly higher levels of lgA2, but not lgA 1, salivary antibodies 
to S. mutans whole cells in caries resistant than in caries 
susceptible adult subjects. However, Smith, King, and Taubman47 
noted that fluctuations in proportions of lgA subclass levels have 
been observed in various age groups. The subclass levels of slgA for 
the 7- to 1 1 -year age group have not been well documented and 
therefore were one of the main foci of this study. 
30 
Also, the need for additional studies in this area has been 
established due to conflicting experimental reports that do not 
support the protective role for salivary antibodies to S. mutans. 
Riviere?s reported in 1 987 that there were no significant 
differences in antibody levels in unstimulated whole saliva and 
dental plaque for any serotype of S. mutans between children of 
different caries experience. However, the potential cross-
reactivity of other bacteria absorbing lgA antibody was not 
considered when whole saliva was used instead of parotid saliva. 
Also, the study failed to document the method, time of day and flow 
rate of unstimulated saliva collection. Other factors that need to be 
addressed by further study include the levels of lgA 1 and lgA2 
antibodies in saliva and the quantitation of S. mutans. 
31 
MATERIALS AND METHODS 
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Demographics 
The study involved a total of 41 subjects who were selected 
from the patient population of the Department of Pediatric 
Dentistry, Indiana University School of Dentistry. The following 
guidelines served as the criteria for patient selection: ( 1 ) the 
patients were all between the ages of 7 and 1 1 years; (2) the 
patients had essentially negative past medical histories; (3) the 
patients were not currently taking any medications; ( 4) the patients 
were in the mixed dentition stage and had at least four permanent 
molars and four permanent incisors; ( 5) each patient's legal 
guardian signed a written informed consent following an explanation 
of the procedure, possible risks and complications; and ( 6) the 
patients were grouped as either caries resistant or caries 
susceptible. 
The definitions of caries resistance and caries susceptible 
were based on statistical data from the National Survey of Dental 
Caries in US School Children compiled by the National Institute of 
Dental Research. 76 Caries-resistant individuals were classified as 
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those individuals who presented with no more than one decayed, 
missing, or filled tooth surfaces. Caries-susceptible individuals 
were classified as those subjects who presented five or more 
unfilled decayed tooth surfaces. The number of five surfaces was 
derived from the US survey data that combines the mean of 
permanent tooth surfaces decayed, missing, or filled and the mean 
of deciduous tooth surfaces decayed, missing, or filled, then 
calculating +2 standard deviations to the 9 5 percentile level to 
arrive at 4. 76 decayed, missing, or filled surfaces. Due to the large 
number of individuals with a relatively low history of caries, the 95 
percentile level is not much greater than the average number of 
decayed, missing or filled surfaces as seen from a clinical 
standpoint. 
Clinical sample collection 
One pediatric dental resident (Dr. PT Rose) in the Department 
of Pediatric Dentistry examined the subjects and collected saliva 
samples. Each subject was seen prior to noon for collection of 
unstimulated parotid and whole saliva to standardize collection 
times. Both parotid and whole saliva were collected so that a 
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comparison of lgA concentrations and antibody levels could be made. 
Whole saliva was collected by having the subjects expectorate into 
a 50 ml tube. Parotid saliva was collected by placing a suction 
adherent apparatus over the parotid duct opening and allowing the 
saliva to flow, unstimulated, into a collection portal. The saliva 
was collected for 20 minutes, then both samples were immediately 
placed on ice and transported to the laboratory. The parotid sample 
was placed immediately at -20 degrees Celsius (C) until needed. A 
portion of whole saliva was used to make dilutions for quantitation 
of microorganisms, and the remaining sample was frozen 
immediately at -20 degrees C. 
Quantitation of S. mutans 
S. mutans was detected in whole saliva samples from all 
subjects by colonial morphology. Briefly, unstimulated saliva 
samples were diluted ( 1:1 0 and 1:1 00) in sterile saline, vortexed for 
30 seconds, and spiral plated in duplicate on Mitis Salivarius agar 
(Difco Laboratories, Detroit, Ml) containing 1 5 percent sucrose 
(MSS) and Mitis Salivarius agar (Difco) containing 15 percent 
sucrose and supplemented with bacitracin (0.2 units/ml) (MSSB) for 
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enumeration of total oral streptococci and S. mutans, respectively, 
after incubation for three days at 37 degrees C in an atmosphere of 
5 percent C02 in air.77 The total oral streptococcal number was 
determined by counting all colonies on each MSS plate and 
correcting for dilution and spiral plating for each sample. The total 
S. mutans number was determined by counting all S. mutans colonies 
on each MSSB plate and correcting for dilution and spiral plating for 
each sample. 
Preparation of enzyme-linked immunosorbent assay antigens 
All 41 subjects' saliva samples were tested by the following 
enzyme-linked immunosorbent assay (ELISA) tests simultaneously in 
order to minimize operator variability. For preparation of S. 
mutans whole cell ELISA antigen, S. mutans TH1 6 (serotype c) cells 
were grown for 18-24 hours at 37 degrees C in 5 percent C02 in a 
dialyzed tryptose broth medium (Difco ), harvested by centrifugation 
(1 0,000 x g; 10 minutes) and washed twice in sterile 0.01 M 
phosphate buffered saline (pH 7.0; PBS). The washed cells were 
resuspended in PBS containing 0. 5 percent formalin and kept for 48 
hours at room temperature to kill the bacteria. The killed cells 
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were washed twice in PBS, and resuspended to an optical density of 
0.500 at 660 nm in 0.1 M sodium bicarbonate/carbonate buffer (pH 
9.6) for use in the ELISA. 
Determination of immunoglobulin concentrations 
and antibody levels 
An ELISA "sandwich" technique was used to determine the 
concentrations of whole salivary total lgA, whole salivary total 
lgA 1, whole salivary total lgA2, and parotid salivary total lgA. One 
hundred JJI of unlabeled goat anti-human lgA (Cappel) that had been 
previously diluted to 1 JJg/ml with carbonate buffer containing 
azide was added to the inner wells of flat-bottomed polystyrene 
microtiter plates (Flow) and allowed to incubate at 37 degrees C for 
three hours. The plates were then washed with Tween saline three 
times and 200 111 of human serum albumin (Sigma) in carbonate 
buffer diluted to 1 0 JJg/ml was added to each well to block 
unreacted sites and the plates were incubated at 2 5 degrees C 
overnight. The saliva samples were diluted (1 :1 0), vortexed for 30 
seconds, and centrifuged for five minutes at 1 ,200 x g. An internal 
control was used to control interplate variability and consisted of 
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aliquots of a large pool of unstimulated saliva from one subject not 
in the study. The plates were washed three times with Tween 
saline and 100 pi of the diluted saliva samples (1 :1 0) as well as 
the whole saliva internal control and the Tween saline negative 
control were added to the wells in triplicate and incubated at 3 7 
degrees C for one hour. Horseradish peroxide-labelled goat 
antihuman lgA, lgA 1, and lgA2 (Cappel) were diluted ( 1:1 000) for 
use in their respective wells. The plates were washed three times 
with Tween saline and 1 00 pi of the anti-human lgA, lgA 1, or lgA2 
was added to each well and was allowed to incubate for one hour. 
The wells were washed three times with Tween saline. One hundred 
111 of the orthophenylene diamine hydrochloride/citrate/HzOz buffer 
was added to each well and allowed to react at room temperature 
for 2 5-30 minutes. The reaction was stopped by adding 1 00 pi of 2 
N H2S04 to all of the wells. The amount of color that developed was 
measured by using the Titertek Multiskan photometer (Flow) at a 
wavelength of 490 nm. The mean internal salivary control 
absorbance for each plate was used to standardize unknown saliva 
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absorbances between plates in order to control for inter-plate 
variability due to temperature, pipetting and reagent differences. 
Levels of whole salivary lgA antibody, whole salivary lgA 1 
antibody, whole salivary lgA2 antibody, and parotid salivary lgA 
antibody levels to S. mutans TH1 6 whole cells were determined by 
ELISA. One hundred JJI of the S. mutans whole cell ELISA antigen 
was added to the inner wells of flat-bottomed polystyrene 
microtiter plates (EIA, Linbro, Flow Laboratories, Mclean, VA). The 
plates were incubated for three hours at 37 degrees C and then 
washed three times with 0.9 percent NaCI containing 0.05 percent 
Tween 20 (Tween-saline) to remove unbound antigen. After the 
final wash, 1 0 JJg/ml of human serum albumin in carbonate buffer 
was added to each well (200 Jll) to block unreacted sites and the 
plates were incubated at 25 degrees C overnight. The saliva 
samples were diluted as discussed earlier. The plates were washed 
three times with Tween saline and the previously optimized 
dilutions of human whole saliva (1 :1 0) were added to each well (1 00 
pi) in triplicate. The internal control was used by placing the 
control saliva ( 1:1 O) in triplicate on all plates and a Tween saline 
negative control was placed in triplicate on all plates. The plates 
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were incubated at 37 degrees C for one hour. The plates were 
washed three more times with Tween saline. Horseradish 
peroxidase-labelled goat anti-human lgA heavy chain-specific 
reagent (Cappel Scientific Division, Cooper Biomedical, Inc., 
Malvern, PA) was diluted (1: 1 000), added to the appropriate wells 
( 1 00 JJI) and incubated at 3 7 degrees C for one hour. The plates 
were washed three times with Tween saline and 1 00 pi of citrate 
buffer ( 0.4 mg of orthophenylene diamine hydrochloride [Sigma 
Chemical, St. Louis, MO]/ml in citrate buffer [pH 5.0] containing 
0.025 percent H202) was added to all the wells and reacted at room 
temperature -for 25-30 minutes. Then, 1 00 pi of 2 N H2S04 was 
added to each well to stop the reaction. The amount of color that 
developed was measured in the microtiter plate by using a Titertek 
Mulitskan photometer (FLOW) at a wavelength of 490 nm. The mean 
internal salivary control absorbance for each plate was used as 
discussed as before. 
Statistical Analysis 
The mean value was calculated by the summation of three 
ELISA absorbances for each sample and dividing by three. Any 
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outlying ( < or > 2 standard deviations from mean) readings were 
excluded from this mean so as to take into consideration any false 
readings. No more than one outlying reading was discarded for any 
individual sample that was examined using the ELISA technique. It 
must be noted that the absorbances for levels of total parotid 
salivary lgA and total whole salivary lgA were converted to semilog 
concentration equivalents by using standard purified secretory lgA 
human colostrum standards. Unless otherwise stated, all variances 
are reported as standard errors of the mean. The BMDP statistical 
analysis program (BMDP Statistical Software, Inc., Los Angeles, CA) 
was used to analyze the values for statistical significance by using 
Student's t test. 
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RESULTS 
42 
Demographics 
There were a total of 41 children in this study. The children 
ranged in age from 7 years 1 month to 11 years 11 months. The 
population consisted of 2 9 caucasian subjects and 1 2 black 
subjects. Fifteen subjects were female and 26 subjects were male. 
S. mutans could be isolated from all 41 subjects regardless of 
caries history. The children were divided into two groups according 
to their caries history: (1) caries resistant (CR); or (2) caries 
susceptible (CS). Not all children donated enough saliva for every 
assay. Demographic breakdowns of the subject population are shown 
in Table I. The mean age (± one standard deviation) of the CR 
children was 9. 78 ± 1.41 years, and the mean age (± one standard 
deviation) of the CS children was 9.46 ± 1.39 years. The relatively 
equal mean ages between the two groups (p > 0.30) is illustrated in 
Figure 2. Age selection for the groups was fairly evenly distributed 
in one-year increments between the 7- to 11-year range as shown 
for the CR and the CS subjects in Figure 3. 
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The CR children had 0.33 ± 0.48 (mean ± one standard 
deviation) decayed, missing, or filled surfaces and the CS children 
had 8.00 ± 2.77 (mean ±one standard deviation) decayed, missing, or 
filled surfaces, which was statistically significant (p < 0.01 ). The 
magnitude of the difference between the CR and the CS individuals 
DMFS scores is shown in Figure 4. A significant difference (p = 
0.002) in sexual distribution was shown between the CR (m = 1 8; f = 
3) and the CS (m = 8; f = 12) individuals in Figure 5. Racial 
distribution was found to be similar (p = 1.00) between the CR (w = 
1 5; b = 6) and the CS (w = 14; b = 6) subjects as shown in Figure 6. 
Quantitation of S. mutans 
Colonial morphology was used to determine the numbers of 
total Streptococcal species in the whole saliva of each patient as 
well as the total numbers of S. mutans in each patient's whole 
saliva. The total oral Streptococcal numbers, the S. mutans 
numbers, and the percentage of S. mutans per total oral streptococci 
of each CR subject are shown in Table II. The Streptococcal 
numbers from colonial morphology for the CS group are listed in 
Table Ill and the percentage of S. mutansltotal oral streptococci are 
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compared between the CR and CS individuals in Figure 7. Included in 
the table are the total S. mutans numbers, the total Streptococcal 
numbers in each subject's whole saliva, and the percentage of S. 
mutans per total oral streptococci for each subject. 
It was found that the salivary S. mutans total numbers were 
significantly higher (p < 0.05) in the CS individuals as compared to 
the CR individuals. The average percentage of S. mutans per total 
oral streptococci was 31.2 percent for the CS individuals and 1.6 
percent for the CR individuals. 
Determination of immunoglobulin concentrations 
and antibody levels 
The mean absorbances for the total lgA concentrations from 
the CR and CS individuals are listed in Table IV and V, respectively. 
The results indicate that the total parotid salivary lgA 
concentrations for the CS and CR individuals were not significantly 
different (p = 0.50). The same was true for the comparison between 
the total whole salivary lgA 1 (p = 0.20) and lgA2 (p = 0.27) 
concentrations. However, the difference between the total whole 
salivary lgA concentrations of the CS and CR groups was significant 
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(p = 0.08). The comparison of total lgA concentrations between CR 
and CS subjects is shown in Figure 9. 
At this point, the absorbance values for total lgA levels were 
converted into concentrations (pg/ml equivalents). This was 
performed by using a purified secretory lgA human colostrum 
standard to create a standard curve using linear regression. The 
equation y = A + B * x was used to plot a linear curve with a 
correlation coefficient of .91 8. The known concentrations of total 
salivary lgA standards were plotted on the x axis, and the mean 
absorbance of each concentration of total salivary lgA standards 
were plotted on the y axis. This linear regression was used to 
calculate the unknown parotid and whole total salivary lgA 
concentrations but could not be used to calculate the total salivary 
lgA 1 or lgA2 concentrations. There are no known well-
characterized lgA 1 or lgA2 standards. The total parotid and whole 
salivary lgA concentrations in pg /ml are listed for the CR and CS 
subjects in Tables VIII and IX, respectively. 
The mean salivary lgA antibody levels to S. mutans for each of 
the CR and CS subjects are presented in Tables VI and VII, 
respectively. Included are the levels of parotid lgA antibody to S. 
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mutans, levels of whole salivary lgA antibody to S. mutans, the 
levels of whole salivary lgA 1 antibody to S. mutans, and the levels 
of whole salivary lgA2 antibody to S. mutans. No significant 
differences were found between the CS and CR individuals when 
comparing the levels of parotid salivary lgA antibody to S. mutans 
(p = 0.43), the levels of whole salivary lgA 1 antibody to S. mutans 
(p = 0.1 9), or the levels of whole salivary lgA2 antibody to S. mutans 
(p = 0.93). However, there was a significant difference noted 
between the CS and CR individual levels of whole salivary lgA 
antibody to S. mutans (p = 0.05). Figure 8 shows a comparison of the 
levels of lgA antibodies to S. mutans between CR and CS subjects. 
In order to make a valid comparison between subject samples, 
proportions of antibody activity to the total immunoglobulin 
concentrations were calculated: ( 1) the proportion of parotid 
salivary lgA antibody to S. mutansltotal parotid salivary lgA; (2) 
the proportion of whole salivary lgA antibody to S. mutans /total 
whole salivary lgA; (3) the proportion of whole salivary lgA 1 
antibody to S. mutansltotal whole salivary lgA; ( 4) the proportion 
of whole salivary lgA 1 antibody to S. mutansltotal whole salivary 
lgA 1 ; ( 5) the proportion of whole salivary lgA2 antibody to S. 
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mutansltotal whole salivary lgA; and (6) the proportion of lgA2 
antibody to S. mutansltotal whole salivary lgA2. Student's t test 
was used to calculate p values for each of the six proportions to 
compare the differences between the CR and CS individuals. 
For each individual parotid sample, the proportion of parotid 
salivary lgA antibody to S. mutans levels/parotid total salivary lgA 
concentration was calculated by dividing the ELISA absorbance of 
each parotid salivary lgA antibody to S. mutans assay by the 
respective concentration of parotid salivary lgA (pg/ml) for that 
given sample. Although the CR group proportions were slightly 
higher than the CS group, the difference was not significant (p = .26) 
as shown in Figure 1 0. 
The proportions of the levels of whole salivary lgA antibody to 
S. mutans/whole total salivary lgA concentration in the whole 
salivary samples was calculated by dividing the whole salivary lgA 
antibody to S. mutans absorbance by the concentraion of whole total 
salivary lgA (pg/ml) for that given sample. It was found that the CR 
group proportions were significantly higher (p = .06) than the CS 
group proportions. The significance of this proportional comparison 
is shown in Figure 1 0. 
48 
The proportions of the levels whole salivary lgA 1 antibody to 
S. mutans/whole salivary total lgA concentrations were calculated 
the same as above. Although the CR group proportions were higher 
than the CS group proportions, the difference was not significant 
(p = .83) as shown in Figure 1 1. 
The proportions of the levels of whole salivary lgA 1 antibody 
to S. mutanslwhole salivary total lgA 1 concentrations was 
calculated the same as above. The CR group proportions were higher 
in comparison to the CS group proportions, but the difference was 
not significant (p = 0.82) as shown in Figure 1 2. 
The proportions of the levels of whole salivary lgA2 antibody 
to S. mutans/whole salivary total lgA concentrations were 
calculated the same as above. The CR and the CS group proportions 
showed relatively equal levels of antibodies in comparison (p = 0. 7 5) 
as shown in Figure 1 1 . 
The proportions of the levels of whole salivary lgA2 antibody 
to S. mutans/whole salivary total lgA2 concentrations were 
calculated the same as above. Although the CS individuals showed a 
slightly greater proportion, it was found that the CR and the CS 
group proportions were not significantly different (p = 0.38) as 
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shown in Figure 1 2. The data for the CR group proportions are 
reported in Tables X and XI, and the results for the CS group 
proportions are found in Tables XII and XIII. 
It should be noted that during statistical analysis any sample 
that was found to be outside 2 standard deviations after a p value 
was calculated, was removed from the sample field and the p value 
was recalculated. A summary of the t test statistics including the 
CR and CS mean values, corresponding standard deviations and p 
values are listed in Tables XIV and XV. 
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TABLE I 
Population characteristics of caries-resistant 
and caries-susceptible subjects 
Total 
Population a 
Age (mean) years 9.62±1 .40 d 
Sex: #of Females 15 
Sex: # of Males 26 
Race: #of Whites 29 
Race: # of Blacks 12 
a Total study population of 41 subjects. 
b Caries-susceptible population of 20 subjects. 
c Caries-resistant population of 21 subjects. 
d Mean age in years ± one standard deviation. 
Caries- Caries-
Susceptible Resistant 
Population b Population c 
9.46±1 .39 9.78±1.41 
12 3 
8 18 
14 1 5 
6 6 
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TABLE II 
Numbers of S. mutans and oral Streptococcal 
species from caries-resistant subjects 
Group and Mean Mean 
Subject # Total Streg a Total S. mutans b 
CR-1 3.1 3E+05 d OE+OO 
CR-2 5.95E+06 9.76E+03 
CR-3 3.61 E+06 2.44E+03 
CR-4 1 .44E+07 2.36E+05 
CR-5 5.22E+06 8.54E+03 
CR-6 1.1 2E+07 4.05E+02 
CR-7 1 .72E+07 2.1 7E+07 
CR-8 1 .53E+07 6.40E+05 
CR-9 1 .57E+07 7.06E+04 
CR-1 0 2.30E+07 2.1 SE+OS 
CR- 1 1 2.20E+06 OE+OO 
CR-1 2 1 .59E+07 5.1 3E+04 
CR-1 3 2.22E+07 5.45E+05 
CR-1 4 1.71 E+07 6.61 E+04 
CR-1 5 1 .85E+06 4.1 SE+OS 
CR-1 6 1 .70E+07 OE+OO 
CR-1 7 4.60E+06 OE+OO 
CR-1 8 1.74E+07 6.71E+04 
CR-1 9 1.26E+07 2.82E+05 
CR-20 3.01 E+06 OE+OO 
CR-2 1 1 .99E+07 1 .02E+03 
CR Mean e 1 .17E+07 1 .16E+06 
+ 7.29E+06 +4.71E+06 
a The mean total Streptococcal count found in each ml of whole saliva. 
b The mean total S. mutans count found in each ml of whole saliva. 
% S. mutans 
of Total Streg c 
0.00% 
0.16% 
0.07% 
1.64% 
0.16% 
0.40% 
100.00% 
0.42% 
0.45% 
0.94% 
0.00% 
0.32% 
2.45% 
0.39% 
22.40% 
0.00% 
0.00% 
0.39% 
2.23% 
0.00% 
0.01% 
1.60% f 
+ 4.83% 
c Total S. mutans count divided by the total Streptococcal count multiplied by 100 percent. 
d Scientific notation expressed as the decimal number followed by the exponentiation symbol E 
and an integer in the form +ii for the exponent. 
e The total mean values for the caries resistant group ± one standard deviation. 
f Significantly different (p = 0.01) than CS group. 
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TABLE Ill 
Numbers of S. mutans and oral Streptococcal 
species from caries-susceptible subjects 
Group and Mean Mean 
Subiect # Total Streg a Total S. mutans b 
CS-301 7.1 3E+06 d 6.91 E+04 
CS-302 1 .07E+06 1 .44E+07 
CS-303 2.48E+07 7.92E+06 
CS-304 2.51 E+07 1 .06E+06 
CS-305 1.01 E+07 1 .88E+07 
CS-306 1.71 E+07 3.1 3E+05 
CS-307 1 .42E+07 6.26E+04 
CS-308 5.1 5E+06 3.46E+05 
CS-309 1 .78E+07 2.05E+05 
CS-3 10 6.39E+06 1.79E+05 
CS-311 4.09E+06 7.11 E+04 
CS-3 1 2 1.92E+06 1.52E+06 
CS-3 1 3 8.03E+06 1.26E+05 
CS-3 14 2.1 1 E+07 2.09E+07 
CS-3 1 5 TNTC e TNTC 
CS-3 1 6 1.58E+07 8.72E+06 
CS-31 7 7.23E+06 5.37E+05 
CS-3 1 8 TNTC TNTC 
CS-3 1 9 TNTC TNTC 
CS-320 1 .17E+07 3.75E+06 
CS Mean g 1.1 7E+07 4.65E+06 
+ 7.60E+06 + 7.02E+06 
a The mean total Streptococcal count found in each ml of whole saliva. 
b The mean total S. mutans ocunt found in each ml of whole saliva. 
% S. mutans 
of Total Streg c 
0.97% 
100.00% 
31.93% 
4.23% 
100.00% 
1.83% 
4.41% 
6.71% 
1.15% 
2.80% 
1.74% 
79.09% 
1.57% 
99.20% 
NDf 
55.21% 
7.42% 
ND 
ND 
32.05% 
31 .19%h 
+39.37% 
c The total S. mutans count was divided by the total Streptococcal count and multiplied by 
1 00 percent. 
d Scientific notation expressed as the decimal number followed by the exponentiation symbol E 
and an integer in the form +ii for the exponent. 
e Too numerous to count (> 1 OE+08). 
f Not determined 
g The total mean values for the caries susceptible group ± one standard deviation. 
h Significantly different (p = 0.01) than CR group. 
Group and 
54 
TABLE IV 
Levels of total lgA, lgA 1 and lgA2 in parotid 
and whole saliva from caries-resistant 
subjects 
Parotid Whole Whole Whole 
Subject # saliva (lgA) saliva (lgA) saliva (lgA 1) saliva (lgA2) 
CR-1 1.379 a 0.842 0.246 0.196 
CR-2 0.057 0.771 0.261 0.226 
CR-3 1.353 0.834 0.232 0.194 
CR-4 1.445 0.610 0.141 0.145 
CR-5 1.359 0.750 0.141 0.180 
CR-6 1.253 0.913 0.249 0.232 
CR-7 1.261 0.907 0.278 0.256 
CR-8 1.437 0.935 0.290 0.227 
CR-9 1.354 1.097 0.329 0.219 
CR-1 0 1.788 0.990 0.489 0.182 
CR- 1 1 0.174 0.787 0.398 0.101 
CR-1 2 1.708 0.958 0.618 0.133 
CR-1 3 1.640 0.943 0.510 0.139 
CR-1 4 1.765 0.880 0.404 0.125 
CR-1 5 1.921 0.922 0.527 0.181 
CR-1 6 1.539 0.790 0.229 0.110 
CR-1 7 1.667 0.753 0.194 0.128 
CR-1 8 1.902 0.980 0.274 0.160 
CR-1 9 2.377 1.045 0.262 0.290 
CR-20 2.154 1.094 0.307 0.288 
CR-2 1 2.505 1.1 14 0.287 0.270 
CR Mean b 1.670 0.910 0.300 0.190 
±0.370 ±0. 120 ±0. 1 10 ±0.060 
a Mean ELISA absorbance at a wavelength of 490 nm. 
b The total mean values ± SO for the caries-resistant group. 
Group and 
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TABLE V 
Levels of total lgA, lgA 1 and lgA2 in parotid 
and whole saliva from caries-susceptible 
subjects 
Parotid Whole Whole Whole 
Subject # saliva (lgA) saliva (lgA) saliva (lgA 1) saliva (lgA2) 
CS-301 1.695 a 0.884 0.266 0.252 
CS-302 1.621 0.747 0.147 0.161 
CS-303 1.548 1.064 0.256 0.217 
CS-304 1.628 0.834 0.203 0.237 
CS-305 1.579 0.912 0.246 0.215 
CS-306 1.949 0.809 0.159 0.175 
CS-307 1.545 0.890 0.213 0.174 
CS-308 1.493 0.899 0.195 0.203 
CS-309 1.486 1.006 0.262 0.229 
CS-3 1 0 1.662 0.872 0.383 0.163 
CS-31 1 1.283 0.872 0.453 0.154 
CS-31 2 1.619 0.669 0.275 0.079 
CS-31 3 1.882 0.829 0.480 0.1 OS 
CS-3 14 1.094 0.749 0.260 0.089 
CS-3 1 5 1.384 0.917 0.350 0.152 
CS-3 1 6 1.436 0.967 0.309 0.125 
CS-3 1 7 1.755 0.970 0.303 0.160 
CS-3 1 8 1.866 0.675 0.135 0.099 
CS-3 1 9 2.005 0.752 0.228 0.174 
CS-320 1.066 0.947 0.327 0.240 
CS Mean b 1.610 0.850 0.260 0.170 
±0.230 ±0.100 ±0.080 ±0.050 
a Mean ELISA absorbance at wavelength of 490 nm. 
b The total mean values ± SD for the caries-susceptible group. 
Group and 
Subject # 
CR-1 
CR-2 
CR-3 
CR-4 
CR-5 
CR-6 
CR-7 
CR-8 
CR-9 
CR-1 0 
CR-1 1 
CR-1 2 
CR-1 3 
CR-1 4 
CR-1 5 
CR-1 6 
CR-1 7 
CR-1 8 
CR-1 9 
CR-20 
CR-2 1 
CR Mean c 
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TABLE VI 
Salivary lgA antibody levels to S. mutans 
from caries-resistant subjects 
Parotid Whole Whole 
saliva (lgA) saliva (lgA) saliva (lgA 1 ) 
0.261 a 0.839 0.245 
- b 0.501 0.169 
0.256 0.124 0.497 
0.458 0.392 0.531 
0.189 0.481 0.245 
0.387 0.684 0.440 
0.395 8.440 0.271 
0.205 1.040 0.211 
0.227 1.790 0.450 
0.207 0.910 0.532 
0.146 0.234 0.355 
0.221 0.935 0.724 
0.343 0.529 0.508 
0.243 0.784 0.453 
0.482 0.640 0.245 
0.279 0.31 1 0.353 
0.303 0.316 0.282 
0.492 2.200 0.389 
0.681 2.070 0.655 
0.294 0.443 0.277 
0.759 1.950 0.407 
0.341 0.810 0.350 
±0. 163 ±0.570 ±0. 130 
a Mean ELISA absorbance at a wavelength of 490 nm. 
b Insufficient volume of saliva. 
c The total mean values ± SD for the caries-resistant group. 
Whole 
saliva (lgA2) 
0.531 
0.386 
0.193 
0.252 
0.236 
0.345 
0.475 
0.305 
0.523 
0.247 
0.187 
0.441 
0.480 
0.225 
0.311 
0.255 
0.243 
0.375 
0.517 
0.286 
0.456 
0.346 
±0.1 20 
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TABLE VII 
Salivary lgA antibody levels to S. mutans 
from caries-susceptible subjects 
Group and Parotid Whole Whole Whole 
Subject # saliva (lgA) saliva (lgA) saliva (lgA 1) saliva (lgA2) 
CS-301 0.325 a 0.474 0.390 0.382 
CS-302 0.199 0.367 0.247 0.242 
CS-303 0.268 2.520 0.709 0.554 
CS-304 0.407 1.390 0.571 0.472 
CS-305 0.284 0.622 0.343 0.357 
CS-306 0.190 0.303 0.306 0.272 
CS-307 0.238 0.974 0.078 0.439 
CS-308 0.333 0.874 0.340 0.373 
CS-309 0.393 0.462 0.373 0.342 
CS-31 0 0.770 0.283 0.291 0.250 
CS-311 0.455 0.648 0.258 0.234 
CS-3 1 2 0.213 0.176 0.181 0.153 
CS-31 3 0.900 0.743 0.564 0.566 
CS-314 0.233 0.283 0.199 0.182 
CS-31 5 0.177 0.183 0.263 0.220 
CS-316 0.155 0.258 0.286 0.325 
CS-317 0.291 0.222 0.688 0.594 
CS-31 8 0.275 0.279 0.242 0.203 
CS-3 1 9 0.357 0.241 0.257 0.213 
CS-320 0.287 3.010 0.376 0.627 
CS Mean b 0.338 0.490 0.320 0.350 
±0.189 ±0.330 ±0.11 0 ±0.150 
a Mean ELISA absorbance at a wavelength of 490nm. 
b The total mean values ± SD for the caries-susceptible group. 
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TABLE VIII 
Concentrations of total salivary lgA from 
caries-resistant subjects converted using 
secretory lgA human colostrum standards 
Group and Parotid Saliva 
Subject # (lgA) 
CR-1 56.61 a 
CR-2 - b 
CR-3 55.04 
CR-4 60.62 
CR-5 55.40 
CR-6 48.97 
CR-7 49.45 
CR-8 60.13 
CR-9 55.10 
CR-1 0 81.43 
CR-1 1 0.00 
CR-1 2 76.57 
CR-1 3 72.45 
CR-1 4 80.03 
CR-1 5 89.50 
CR-1 6 66.32 
CR-1 7 74.09 
CR-1 8 88.34 
CR-1 9 1 1 7.1 6 
CR-20 103.63 
CR-2 1 124.93 
CR Mean c 74.51 
±22.24 
a Total salivary lgA concentrations (Jlg/ml). 
b Insufficient sample 
c The total mean values ± SO for the caries-resistant group. 
Whole Saliva 
(lgA) 
24.03 
19.73 
23.55 
9.96 
18.45 
28.34 
27.98 
29.68 
39.50 
33.01 
20.70 
31.07 
30.16 
26.34 
28.89 
20.88 
18.63 
32.41 
36.35 
39.32 
40.54 
27.60 
±7.94 
Group and 
Subject # 
CS-301 
CS-302 
CS-303 
CS-304 
CS-305 
CS-306 
CS-307 
CS-308 
CS-309 
CS-31 0 
CS-311 
CS-312 
CS-31 3 
CS-314 
CS-31 5 
CS-31 6 
CS-317 
CS-31 8 
CS-31 9 
CS-320 
CS Mean b 
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TABLE IX 
Concentrations of total salivary lgA from 
caries-susceptible subjects converted using 
secretory lgA human colostrum standard 
Parotid Saliva Whole Saliva 
(lgA) (lgA) 
75.78a 26.58 
71.29 18.27 
66.87 37.50 
71.72 23.55 
68.75 28.28 
91.19 22.03 
66.68 26.95 
63.53 27.49 
63.10 33.98 
73.78 25.85 
50.79 25.85 
71.17 13.54 
87.13 23.25 
39.32 18.39 
56.92 28.58 
60.07 31.62 
79.42 31.80 
86.16 13.90 
94.59 18.57 
37.62 30.40 
68.79 25.32 
+ 15.32 + 6.45 
a Total salivary lgA concentrations (JJg/ml). 
b The total mean values± SO for the caries-susceptibie group. 
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TABLE X 
Proportion of salivary lgA antibody to S. mutansl 
total lgA levels from caries-resistant subjects 
Parotid saliva Whole saliva Whole saliva 
Subject (lgA I lgA) (lgA I lgA) (lgA 1 I lgA) 
CR-1 0.005 a 0.035 0.021 
CR-2 - b 0.025 0.023 
CR-3 0.005 0.005 0.010 
CR-4 0.008 0.039 0.035 
CR-5 0.008 0.026 0.015 
CR-6 0.003 0.024 0.014 
CR-7 0.008 0.602 0.023 
CR-8 0.003 0.035 0.009 
CR-9 0.004 0.045 0.010 
CR-1 0 0.003 0.028 0.007 
CR-11 0.003 0.011 0.008 
CR-12 0.005 0.030 0.016 
CR-1 3 0.003 0.018 0.018 
CR-1 4 0.005 0.030 0.009 
CR-1 5 0.004 0.022 0.015 
CR-16 0.004 0.015 0.013 
CR-17 0.006 0.017 0.011 
CR-1 8 0.006 0.068 0.014 
CR-1 9 0.003 0.029 0.015 
CR-20 0.006 0.011 0.009 
CR-2 1 0.004 0.048 0.018 
CR Mean c 0.005 d 0.028 e 0.014 f 
±0.005 ±0.020 ±0.01 0 
a Mean ELISA absorbance of lgA to S. mutans divided by the mean totallgA concentration. 
b Insufficient sample. 
c The total mean values ± SD for the caries-resistant group. 
d Comparison to caries susceptible; (p = 0.73). 
e Comparison to caries susceptible; (p = 0.06). 
f Comparison to caries susceptible; (p = 0.83). 
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TABLE XI 
Proportion of salivary lgA antibody to 5. mutans/ 
total lgA levels from caries-resistant subjects 
Group and 
Subject # 
CR-1 
CR-2 
CR-3 
CR-4 
CR-5 
CR-6 
CR-7 
CR-8 
CR-9 
CR-1 0 
CR-11 
CR-12 
CR-13 
CR-14 
CR-15 
CR-16 
CR-17 
CR-18 
CR-19 
CR-20 
CR-21 
CR Mean b 
Whole saliva 
(lgA 1 I lgA 1 ) 
2.065 a 
1.736 
1.056 
2.504 
2.000 
1.562 
2.356 
0.955 
1.237 
0.501 
0.425 
0.804 
1.041 
0.606 
0.835 
1.183 
1.088 
1.640 
2.031 
1.156 
2.523 
1.430 c 
±0.660 
Whole saliva 
(lgA2 I lgA) 
0.022 
0.020 
0.008 
0.025 
0.013 
0.012 
0.017 
0.010 
0.013 
0.007 
0.009 
0.014 
0.016 
0.009 
0.011 
0.012 
0.013 
0.023 
0.014 
0.007 
0.011 
0.013 d 
±0.01 0 
Whole saliva 
(lgA2 I lgA2) 
2.709 
1.708 
0.995 
1.738 
1.311 
1.487 
1.855 
1.344 
2.388 
1.357 
1.851 
3.316 
3.453 
1.800 
1.718 
2.318 
1.898 
2.344 
1.783 
0.993 
1.689 
1.910 e 
±0.660 
a Mean ELISA absorbance of lgA to S. mutans divided by the mean totallgA concentration. 
b The total mean values ±SO for the caries-resistant group. 
c Comparison to caries susceptible; (p = 0.82). 
d Comparison to caries susceptible; (p = 0. 7 5). 
e Comparison to caries susceptible; (p = 0.38). 
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TABLE XII 
Proportion of salivary lgA antibody to S. mutans! 
total lgA levels from caries-susceptible subjects 
Group and Parotid saliva Whole saliva Whole saliva 
Subject # (lgA I lgA) (lgA I lgA) (lgA 1 I lgA) 
CS-301 0.004 a 0.018 0.015 
CS-302 0.003 0.020 0.014 
CS-303 0.004 0.067 0.019 
CS-304 0.006 0.059 0.024 
CS-305 0.004 0.022 0.012 
CS-306 0.002 0.014 0.014 
CS-307 0.004 0.036 0.003 
CS-308 0.005 0.032 0.012 
CS-309 0.006 0.014 0.011 
CS-3 1 0 0.010 0.011 0.01 1 
CS-3 1 1 0.009 0.025 0.010 
CS-3 1 2 0.003 0.013 0.013 
CS-313 0.010 0.032 0.024 
CS-314 0.006 0.015 0.011 
CS-3 1 5 0.003 0.006 0.009 
CS-3 1 6 0.003 0.008 0.009 
CS-317 0.004 0.007 0.022 
CS-31 8 0.003 0.020 0.017 
CS-31 9 0.004 0.013 0.014 
CS-320 0.008 0.099 0.012 
CS Mean b 0.004 c 0.020 d 0.014 e 
±0.002 ±0.01 0 ±0.01 0 
a Mean ELISA absorbance of lgA to S. mutans divided by the mean totallgA concentration. 
b The total mean values ± SD for the caries-susceptible group. 
c Comparison to caries resistant; (p = 0.26). 
d Comparison to caries resistant; (p = 0.06). 
e Comparison to caries resistant; (p = 0.83). 
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TABLE XIII 
Proportion of salivary lgA antibody to S. mutans! 
total lgA levels from caries-susceptible subjects 
Group and Whole saliva Whole saliva Whole saliva 
Subject # (lgA 1 I lgA 1) (lgA2 I lgA) (lgA2 I lgA2) 
CS-301 1.466 a 0.014 1.516 
CS-302 1.680 0.013 1.503 
CS-303 2.770 0.015 2.553 
CS-304 2.813 0.020 1.992 
CS-305 1.394 0.013 1.660 
CS-306 1.925 0.010 1.554 
CS-307 0.366 0.016 2.523 
CS-308 1.744 0.014 1.837 
CS-309 1.424 0.010 1.493 
CS-3 10 0.760 0.010 1.534 
CS-3 1 1 0.570 0.010 1.937 
CS-3 1 2 0.658 0.011 1.519 
CS-3 1 3 1.175 0.024 5.390 
CS-3 14 0.765 0.010 2.045 
CS-3 1 5 0.751 0.008 1.447 
CS-3 1 6 0.926 0.010 2.600 
CS-3 1 7 2.271 0.019 3.713 
CS-3 1 8 1.793 0.015 2.051 
CS-3 1 9 1.127 0.011 1.224 
CS-320 1.150 0.021 2.613 
CS Mean b 1.390 c 0.014 d 2.140 e 
±0.710 ±0.01 0 ±0.220 
a Mean ELISA absorbance of lgA to S. mutans divided by the mean total lgA concentration. 
b The total mean values ± SO for the caries-susceptible group. 
c Comparison of caries resistant; (p = 0.82). 
d Comparison of caries resistant; (p = 0.75). 
e Comparison of caries resistant; (p = 0.3 8). 
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TABLE XIV 
Summary of t test statistics 
Sample CR Mean CS Mean P Value a 
Parotid lgA Ab 0.34 + 0.16 b 0.34 + 0.19 0.82 
to S. mutans 
Parotid Total 1.67 + 0.37 c 1.61 + 0.23 0.50 
lgA 
Whole lgA Ab 0.81 + 0.57 b 0.49 + 0.33 0.05 
to S. mutans 
Whole Total 0.91 + 0.12 c 0.85+0.10 0.08 
lgA 
Whole lgA 1 Ab 0.38 + 0.13 b 0.32 + 0.11 0.19 
to S. mutans 
Whole Total 0.30 + 0.1 1 c 0.26 + 0.08 0.20 
lgA1 
Whole lgA2 Ab 0.35 + 0.12 b 0.35 + 0.15 0.93 
to S. mutans 
Whole Total 0.19 + 0.06 c 0.17 + 0.05 0.27 
lgA2 
a P value calculated using Student's t test. 
b Mean ELISA absorbance at 490 nm ±standard deviation. 
c Mean total salivary lgA concentration ( pg I ml) ± standard deviation. 
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TABLE XV 
Summary of t test statistics 
Sample CR Mean CS Mean P Value a 
Parotid lgA Ab 0.005 + 0.002 b 0.005 + 0.002 0.73 
to S. mutans 
I Total lgA 
Whole lgA Ab 0.03 + 0.02 0.02 + 0.01 0.06 
to S. mutans 
I Total lgA 
Whole lgA 1 Ab 0.01 + 0.01 0.01 + 0.01 0.83 
to S. mutans 
I Total lgA 
Whole lgA 1 Ab 1.43 + 0.66 1.39 + 0.71 0.82 
to S. mutans 
I Total lgA 1 
Whole lgA2 Ab 0.01 + 0.01 0.01 + 0.01 0.75 
to S. mutans 
I Total lgA 
Whole lgA2 Ab 1.91 + 0.66 2.14 + 0.22 0.38 
to S. mutans 
I Total lgA2 
a P value calculated using Student's t test. 
b Mean ELISA absorbance at 490 nm of lgA antibody to S. mutans divided by the mean total 
salivary lgA concentration (pg/ml). 
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Figure 1. Demonstration of lgA:J chain translocation 
from subepithelial areas to external 
secretions by secretory component. 
Chronological Age of CR and CS Subjects 
10 
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FIGURE 2. Chronological age in years of caries-resistant and 
caries-susceptible subjects. 
Age of Caries Resistant Subjects Age of Caries Susceptible Subjects 
• 7-8 yrs 15.0% 
8 8-9 yrs 10.0% 
• 9-10 yrs 25.0% 
EJ 1 0-11 yrs 25.0% 
C1 11-12 yrs 25.0% 
FIGURE 3. Subject distribution of each year of age for the 
caries-resistant and caries-susceptible subjects. 
• 7-8 yrs 15.8% 
~ 8-9 yrs 26.3% 
• 9-10 yrs 26.3% 
f2l 1 0-11 yrs 10.5% 
lJ 11-12 yrs 21.1% 
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ITI CR WLJcs 
FIGURE 4. Comparison of the number of decayed, m1ss1ng, or 
filled tooth surfaces from caries-resistant and 
caries-susceptible subjects as detected upon oral and 
radiographic examination. 
Distribution by Sex of CR Subjects Distribution by Sex of CS Subjects 
FIGURE 5. 
• Males 85.7% 
~Females 14.3% 
Distribution by sex of the caries-resistant and 
caries-susceptible subjects. 
• Males 40.0% 
~ Females 60.0% 
Racial Distribution of CR Subjects Racial Distribution of CS Subjects 
• White 71.4% 
EJ Black 28.6% 
FIGURE 6. Distribution by race of the caries-resistant and 
caries-susceptible subjects. 
• White 70.0% 
rB Black 30.0% 
Comparison of Percent S. mutans from Subjects 
0.320 
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FIGURE 7. 
0.000 
filleR ~cs 
Comparison of percentage of S. mutans!total oral 
streptococci from caries-resistant and 
caries-susceptible subjects determined by colonial 
morphology from spiral plated cultures. 
Absorbance 
Levels of lgA Antibodies to S. mutans 
0.90 
0.81 
Parotid lgA 
DCR ~CS 
Whole lgA * Whole lgAl 
FIGURE 8. Comparison of levels of lgA antibodies to S. mutans from 
caries-resistant and caries-susceptible subjects 
determined by ELISA. * (p = 0.05) 
Whole lgA2 
JJg/ml 
Total lgA Concentrations 
1.70 
0.00 
Parotid lgA Whole lgA * Whole lgA1 
DcR ~cs 
FIGURE 9. Comparison of total lgA concentrations from 
caries-resistant and caries-susceptible subjects 
determined by ELISA. * (p = 0.08) 
Whole lgA2 
Absorbance/ 
JJg/ml 
0.030 
0.027 
0.021 
Proportions of lgA/Total lgA 
Parotid lgA Ab/lgA 
OCR ~CS 
Whole lgA Ab/lgA * 
FIGURE 1 0. Comparison of the proportions of lgA antibody to S. 
muta nsf total lgA in parotid saliva or whole saliva from 
caries-resistant and caries-susceptible subjects 
determined by ELISA. *(p = 0.06) 
Absorba nee/ 
JJQ/ml 
Proportions of lgA/Total lgA 
0.011 0 
0.0000 
Whole lgA 1 Ab/lgA 
DCR ~CS 
Whole lgA2 Ab/lgA 
FIGURE 1 1 . Comparison of the proportions of lgA 1 and lgA2 
antibody to S. mutans!total lgA in whole saliva from 
caries-resistant and caries-susceptible subjects 
determined by ELISA. 
Absorbance/ 
JJQ/ml 
Proportions of lgA/Total lgA 
2.20 
Whole lgA 1 Ab/lgA 1 
DcR ~cs 
Whole lgA2 Ab/lgA2 
FIGURE 12. Comparison of the proportions of lgA 1 antibody to S. 
mutans/total lgA 1 and lgA2 to S. mutans/total lgA2 
in whole saliva from caries-resistant and 
caries-susceptible subjects determined by ELISA. 
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DISCUSSION 
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It has been previously reported by Camling, Gahnberg and 
KrasseS4 that there is a correlation between the degree of caries 
activity and total salivary lgA concentrations and also between the 
DMFS score and total salivary lgA concentrations. The same group 
also reported that most high-caries subjects had high salivary 
numbers of S. mutans and that any attempts to relate the level of 
lgA antibodies in whole saliva to the prevalence of caries in an 
individual should take into consideration the number of salivary S. 
mutans. For these reasons the present study not only examined 
patients with different levels of caries activity as it related to 
their salivary lgA concentrations, but also took into consideration 
what each of their total Streptococcal and S. mutans counts were at 
the time of saliva collection. In this way, it could be shown that 
not only were the individual caries activity levels compared with 
the corresponding salivary lgA concentrations but also that each 
subject had varying numbers of S. mutans in their whole saliva. 
The present study supports previous investigations that found 
that subjects with higher caries activity levels had significantly 
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higher numbers of S. mutans in their whole saliva. The study was 
designed to examine the total Streptococcal and S. mutans numbers 
for each patient and to divide the S. mutans numbers by the total 
oral Streptococcal numbers to calculate the proportion of S. mutans 
for each sample. 
Gregory et al.61 ,69,70 and other investigators reported a 
correlation between lower rates of caries activity and higher levels 
of salivary lgA antibody levels to S. mutans. It was also reported 
that lgA 1 and lgA2 antibodies may inhibit S. mutans virulence 
factors and suggest that lgA2 may be more effective than lgA 1 at 
this function. The current study supported findings from these 
studies in that the levels of whole salivary lgA antibody to S. 
mutans were higher in caries-resistant subjects than the caries-
susceptible subjects. 
It was found in this investigation that the total whole 
salivary lgA concentrations, the levels of whole salivary lgA 
antibody to S. mutans, and the mean proportions of the level of 
whole salivary lgA antibody to S. mutans/total whole salivary lgA 
concentration were significantly higher in the caries-resistant 
subjects as compared to the caries-susceptible subjects. The total 
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parotid salivary lgA concentrations, the levels of parotid salivary 
lgA antibody to S. mutans level and the mean proportions of the 
level of whole salivary lgA antibody to S. mutans/total whole 
salivary lgA concentrations were found not to be significantly 
different in the caries-resistant versus caries-susceptible 
subjects. Also, the total whole salivary lgA 1 concentrations, the 
levels of whole salivary lgA 1 antibody to S. mutans and the 
proportions of the level of whole salivary lgA 1 antibody to S. 
mutans/total whole salivary lgA concentrations and the total whole 
salivary lgA 1 concentrations were found not to be significantly 
different between the caries-resistant individuals and the caries-
susceptible individuals. 
In dispute with previous studies, the levels of whole salivary 
lgA2 antibody to S. mutans levels were found to be relatively equal 
in the caries-resistant subjects as compared to the caries-
susceptible subjects. Several explanations for this can be made. 
One explanation is that, as already reported, the actual proportions 
and concentrations of secretory lgA 1 and lgA2 may shift in children 
from birth until adulthood is reached. Previous studies by Taubman 
and Smith51 have shown that in children examined in the predentate 
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stage there were general population as well as individual 
fluctuations in lgA subclass levels. 
Another explanation for this finding may be that antigenic 
cross-reactivity between lgA antibody to S. mutans and other 
bacterial species in the oral cavity exist and that the other bacteria 
are absorbing the lgA in whole saliva. A third explanation may be 
that since there is actually no reliable method to determine which 
subjects are currently exhibiting active or inactive caries 
progression in a cross-sectional study, then the actual clinical 
division of caries-resistant and caries-susceptible subjects cannot 
be determined. Attempts were made to divide the caries-
susceptible group into active and inactive decay groups by 
determining the caries history based on clinical examination 
including oral exam and radiographs. The limited comparisons made 
were relatively equivalent but were not pursued based on the 
unreliable method of subject separation into caries-active and 
caries-inactive categories. The degree of caries activity caul~ 
influence the type and number of bacteria present at the time of 
saliva collection, which would affect salivary lgA antibody levels. 
Another explanation for the findings is that the potential exists for 
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other microorganisms, which are cross-reactive with S. mutans, to 
be present in children in different numbers as compared to adult 
numbers. 
More so with children than with other age groups, collection of 
saliva can sometimes be difficult due to variations in attention 
span, anxiety, and the ability to cooperate. Most children selected 
for this study were well behaved, willing patients but some lacked 
enough understanding and patience to remain comfortable for the 
period of time required for saliva collection. In some instances it 
was impossible to prevent external stimulation of saliva flow from 
the collection apparatus itself, but it was felt that every patient 
provided samples that would certainly maintain any guidelines put 
forward to this age range of subjects. 
It is obvious in any clinical study that there is a wide 
fluctuation in environmental factors including such things as 
individual dietary habits and oral hygiene. These factors were 
controlled as well as possible by patient selection but may be 
better accounted for by using plaque to quantitate bacterial levels. 
Flow rates may be influenced by the time of day and anticipation of 
meals and activities which could decrease or increase the flow 
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rates. Flow rate is not considered constant but peaks with 
individual differences in relation to daily events. For this reason it 
was attempted to collect all samples in the morning hours but 
individual habits of meal times and activity levels may influence 
the outcome. Patient anxiety can also influence salivary 
flow rate. Some children are somewhat apprehensive about visiting 
the dentist no matter what the procedure. Approximately one half 
of the subjects for this study were placed in isolated, quiet rooms 
with little external distraction and the other half were placed in an 
open bay office setting with somewhat considerable external 
stimulation during the saliva collection. To what extent this may 
influence the saliva quality is unknown but it is suggested in the 
future to collect samples from all subjects under similar 
environmental standards. It was observed that patients left 
undisturbed in quiet room surroundings had an overall easier time 
with the collection apparatus and provided larger sample volumes 
although individual differences remained. 
Two approaches were used to help correct any differences in 
flow rate between individuals. The first approach was the 
determination of the percentage S. mutans/total Streptococci for 
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each individual. The second approach was the determination of the 
total lgA/ml. This provided the equivalent information that would 
have been obtained from measuring the flow rate of each individual. 
Two major influences on statistical significance are study 
design and sample size. Both of these factors were restricted due 
to time constraints. In the future a larger sample size would help 
establish a more reliable statistical evaluation. Cross sectional 
studies relate information in a more affordable and more timely 
manner, but it would be wise to conduct a combination cross 
sectional/longitudinal study in order to study individuals of varying 
ages with multiple sample analysis. 
This investigation of the role of the immune response in 
natural protection against caries in children has clinical 
importance. This study indicates that the secretory immune 
response against S. mutans provides higher levels of resistance 
against dental caries in subjects with higher levels of slgA. This 
study compared and documented the levels of lgA, lgA 1 and lgA2 
antibody to S. mutans for 7- to 11-year-old subjects so that a 
better understanding of fluctuation patterns in this age group could 
be obtained for future reference. This age range is important in that 
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it is the age of highest caries activity and these children would 
benefit the most from an enhanced immune response. As the data 
from this study indicate, the antibody levels to S. mutans can be 
used to identify those individuals who are at high risk for dental 
caries and they could be especially helpful in the 7- to 1 1 -year age 
range. If those individuals at high caries risk could be identified 
then the possibility exists that their natural immune response could 
be enhanced (vaccination I immunization) resulting in a reduced 
caries rate. This could also provide information to clinicians that 
could initiate a more aggressive preventive program including the 
use of fluorides, pit and fissure sealants, and other preventive 
measures beyond the normal guidelines. 
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SUMMARY AND CONCLUSIONS 
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Developed countries have instituted programs to decrease 
dental caries such as water fluoridation, regular dental care, and 
increased awareness of contributing dietary factors. However, 
dental caries remains as the most common disease found in man. It 
is believed that if the body's immune system could be stimulated to 
produce more antibody to neutralize bacteria, then the caries rate 
could be reduced. It is thought that there is a relationship between 
the caries rate and the level of lgA2 antibodies to S. mutans. The 
purpose of this study was to determine the relationship between 
these two conditions and to make a comparison between caries-
resistant and caries-susceptible children. This was performed by 
collecting parotid and whole saliva, quantitation of S. mutans, and 
ELISA analysis of total lgA concentrations and lgA antibody levels. 
It was found that the lgA antibody levels to S. mutans in whole 
saliva were significantly higher (p < 0.05) in caries-resistant 
subjects than the caries-susceptible subjects, but only slightly 
higher in parotid salivary lgA and whole salivary lgA 1 antibody 
levels in comparison. It was also found that the lgA2 antibody 
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levels to S. mutans between the two groups were relatively 
equivalent. The conclusions from this study were that lgA antibody 
levels to S. mutans were higher in caries resistant subjects than in 
caries susceptible subjects but that a relationship could not be 
established between the lgA 1 and lgA2 antibody levels to S. mutans 
and the degree of caries activity. 
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ABSTRACT 
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A COMPARISON OF IGA ANTIBODY LEVELS 
IN CARIES-RESISTANT AND CARIES-
SUSCEPTIBLE CHILDREN 
by 
Paul Todd Rose 
Indiana University School of Dentistry 
Indianapolis, Indiana 
Secretory immunity is believed to play a role in natural 
resistance to dental caries. Although dental caries has dramatically 
decreased in children in the United States, there remains a 
population of caries-susceptible children even in fluoridated 
communities. Previous studies have shown a positive correlation 
between salivary immunoglobulin A (slgA) antibody levels to 
Streptococcus mutans and caries resistance in adults. In the 
present study, an enzyme-linked immunosorbent assay (ELISA) was 
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used to compare lgA antibody levels to S. mutans in saliva from 20 
caries susceptible (DMFS greater than 5) and 20 caries-resistant 
(DMFS less than or equal to 1) children (ages 7-11 ). All subjects 
resided in fluoridated communities. Salivary S. mutans numbers 
were significantly higher (p ~ 0.05) in the caries susceptible (31 .2 
percent of total streptococci) group than in the caries resistant ( 1 . 6 
percent of total streptococci) group. Whole saliva from caries-
resistant children had significantly higher (p = 0.05) levels of lgA 
antibodies to S. mutans than saliva from caries-susceptible 
children. However, whole saliva from caries-resistant children had 
similar levels of lgA 1 or lgA2 antibodies against S. mutans to saliva 
from caries-susceptible children. These results suggest that lgA 
antibody to S. mutans may play a role in natural protection from 
dental caries in children and confirm previous reports indicating a 
role for salivary lgA antibodies to S. mutans in mediation of caries. 
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